Skip to main content

Table 2 Multivariate analysis for OS and DFS of 90 CRC patients

From: miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4

Variables

OS

DFS

HR

95% CI

P

HR

95% CI

P

Tumor invasion (T1/T2 vs T3/T4)

0.82

(0.33-2.00)

0.658

0.77

(0.31-1.90)

0.567

Lymph node status (<1 vs ≥1)

2.35

(1.25-4.41)

0.008*

2.43

(1.30-4.59)

0.006*

Distant metastasis (Absent vs Present)

7.89

(4.58-13.61)

<0.001*

9.41

(5.49-16.16)

<0.001*

TNM stage (I/II vs III/IV)

1.61

(1.01-2.59)

0.049*

1.77

(1.10-2.86)

0.019*

miR-296 expression (Low vs High)

0.44

(0.22-0.86)

0.016*

0.43

(0.27-1.02)

0.038*

  1. OS overall survival, DFS disease-free survival, CRC colorectal cancer, TNM tumor-node-metastasis. * Statistically significant